Product Liability
May 16, 2008
FDA Pre-emption Under Scrutiny
The Bush administration's expanded use of federal pre-emption when it comes to oversight of drugs and medical devices is now coming under the microscope in Congress.
Daily Journal Staff Writer
This article appears on Page 1
WASHINGTON - The Bush administration's expanded use of federal pre-emption when it comes to oversight of drugs and medical devices is now coming under the microscope in Congress.
At a House of Representatives Oversight and Government Reform Committee hearing Wednesday, Los Angeles Democrat Rep. He...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In